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Abstract
Background: Widespread use of high-throughput techniques such as microarrays to monitor
gene expression levels has resulted in an explosive growth of data sets in public domains.
Integration and exploration of these complex and heterogeneous data have become a major
challenge.
Results: The EXALT (EXpression signature AnaLysis Tool) online program enables meta-analysis
of gene expression profiles derived from publically accessible sources. Searches can be executed
online against two large databases currently containing more than 28,000 gene expression
signatures derived from GEO (Gene Expression Omnibus) and published expression profiles of
human cancer. Comparisons among gene expression signatures can be performed with homology
analysis and co-expression analysis. Results can be visualized instantly in a plot or a heat map. Three
typical use cases are illustrated.
Conclusions: The EXALT online program is uniquely suited for discovering relationships among
transcriptional profiles and searching gene expression patterns derived from diverse physiological
and pathological settings. The EXALT online program is freely available for non-commercial users
from http://seq.mc.vanderbilt.edu/exalt/.
Background
Microarray technology enables simultaneous measure-
ments of thousands of gene expression levels in parallel.
An overwhelming amount of gene expression data has
been generated across a wide spectrum of diseases and
experimental conditions. The public repositories, Gene
Expression Omnibus (GEO) at the National Center for
Biotechnology Information (NCBI) [1] and ArrayExpress
at the European Bioinformatics Institute[2], have been
established to store microarray data sets. However, these
Published: 14 December 2009
BMC Bioinformatics 2009, 10:420 doi:10.1186/1471-2105-10-420
Received: 29 June 2009
Accepted: 14 December 2009
This article is available from: http://www.biomedcentral.com/1471-2105/10/420
© 2009 Wu et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7
(page number not for citation purposes)
BMC Bioinformatics 2009, 10:420 http://www.biomedcentral.com/1471-2105/10/420data are neither intuitively meaningful nor directly com-
parable. A critical challenge is how to utilize these data
sets to maximize the information gained.
Efforts have been made to improve microarray data utili-
zation by providing summarized microarray results. As
examples, GEO provides gene expression profiles for a
given data set, while Oncomine computes significant gene
lists from published cancer studies based on common
experimental design [3]. A specific pattern or signature of
gene expression deduced from a set of differentially
expressed genes can be a powerful biomarker. This can be
used for determining drug responses, clinical outcomes,
and disease diagnosis such as cancer, organ transplant
rejection, diabetes, and viral infection [4-9]. Indeed for
some diseases, ascertainment of gene expression signa-
tures is rapidly becoming the standard of care for deter-
mining disease prognosis and formulating personalized
therapy [10].
However with the GEO website, a user can only compare
gene expression levels within a given data set. Oncomine
makes meta-analysis available by offering pre-processed
signatures from published cancer studies, but data sets in
Oncomine can only be queried by gene name or experi-
mental keyword rather than by a signature. All profile
analysis reports in Oncomine are based on sample groups
and significant genes within the selected data set. Hence,
search entries in GEO or Oncomine are limited to meta-
data attributes from experiment descriptions, sample
information, and probe IDs rather than the expression
data themselves. Neither system supports a signature
comparison or a signature similarity search across all data
sets. It remains difficult to ask targeted biological ques-
tions at the signature level by querying microarray results
across a large collection of data sets.
We previously described a bioinformatic strategy (EXALT)
to enable comparisons of microarray data across experi-
mental platforms, different laboratories, and multiple
species [11]. EXALT uses gene expression signatures
extracted from expression values to query a large format-
ted collection of microarray results. We accomplished this
by first transforming a large collection of gene expression
data into a rank ordered format of differentially expressed
gene signatures within each experiment. EXALT offers an
efficient and cost-effective way to discover intrinsic simi-
larities and relationships among gene expression profiles.
We have now implemented a web-enabled version of
EXALT (EXALT online) with enhanced functionality and
ready access to two expansive databases of gene expres-
sion signatures (currently > 28,000). The gene expression
signatures are derived from GEO and published transcrip-
tional profiling studies of human cancer. The EXALT
online program provides an easy-to-use web-interface for
executing multiple query types to search for homologous
signatures online - a feature not offered by any other cur-
rently available web-based tools.
Implementation
The EXALT online program organizes genes exhibiting sig-
nificant differences in expression within an experiment in
a special format called a "triplet". A "triplet" includes a
gene identifier, a direction of differential expression, and
a confidence level called Q score. All signatures are
extracted using the same statistical method [11]. A signa-
ture defined by the EXALT online program is a set of sig-
nificant genes with their corresponding statistical scores
and direction codes.
Data sources
GEO GDS sets were processed into signatures in batch
mode using EXALT. Published human cancer expression
profiling studies were identified in PubMed by a search
strategy using keywords "human", "cancer", and "micro-
array". From a total of 1,062 publications, 310 studies had
publically available data that could be manually curated.
Signature extraction
A 4-step process was used to extract gene expression signa-
tures from individual human cancer data sets. First, data
were manually formatted to a common data type. Second,
we tested each gene for significant differential expression
using a common statistical method. The P-values deter-
mined for each significant gene were adjusted by the false
discovery rate (FDR) method using Q values [12]. Q val-
ues were then converted to the logarithm of the reciprocal
for the Q scores (-log[Q value]). Third, a list of significant
genes with a Q value ≤ 0.2 was produced. Finally, gene
expression signatures were encoded in the form of a list of
"triplets". A triplet format was defined as a Gene symbol -
Direction Code - Q score. The direction code was deter-
mined by the relative difference between two group
means and could have one of three values (U, up; D,
down; X, uncertain). Signatures were stored in a relational
database linked with clinical outcome data and experi-
mental features from the original study.
Signature databases
Gene expression signatures derived from GEO and pub-
lished human cancer studies were stored in two separate
relational signature databases, i.e. GEO signature data-
base (SigDB) and human cancer SigDB (HuCaSigDB). The
current databases are limited to samples derived from
human, mouse, and rat. They contain 25,613 signatures
derived from 1,445 data sets in GEO and 2,391 human
cancer signatures from 532 data sets from published
human cancer studies. The current version of HuCaSigDB
is highly enriched in studies of human breast cancer.Page 2 of 7
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The EXALT online program enables comparisons of gene
expression signatures in both GEO SigDB and
HuCaSigDB using the same algorithms as we described
before [11]. Data access can be initiated from multiple
search entries. During a search for homologous signa-
tures, query genes are compared to all subject signature
genes in the database. The similarity between a query sig-
nature and a subject signature is first determined by gene
symbol match and concordance in the direction of differ-
ential expression. Then, a normalized total identity score
is calculated based on Q scores from the query and the
subject signature. The significance level of the similarity is
determined by a simulation analysis [11]. Significant
matching results between a query and subject signatures
are displayed graphically. When users enter a single gene
or a set of gene symbols for co-expression analysis, a reg-
ular database search is performed based on query gene
symbols.
System architecture
The EXALT online program was implemented using
Microsoft .Net technology with typical three-tiered archi-
tecture. A standalone web server is in charge of user query
data processing and result presentation while an inde-
pendent application server provides web services for data
analysis and query process. A relational database manage-
ment system (RDBMS) manages signature data storage
and retrieval. This type of architecture allows for concur-
rent and remote access to many users in a scalable and
reliable way.
The implementation of web application logic and user
interfaces was achieved by using ASP.NET 2.0, which is an
integral part of the .NET Framework 2.0. ASP.NET was
chosen because of its productivity gains and powerful
libraries for image processing and database access. The
data query and analysis algorithms were implemented by
internet application programming interfaces (web service
API). The web services can be accessed over a network and
executed on a remote application server hosting the
requested services. The EXALT online program application
has been successfully tested on internet browsers from
Microsoft Window, Mac OS X, and Linux X Window.
Results
The EXALT online program interface facilitates the
uploading of user data, database searching, and compar-
ing signatures. We previously described the user data
uploading process and a general strategy to compare gene
expression signatures among microarray data sets [11].
The new EXALT online program enables online keyword
searching, signature homology analysis, and gene co-
expression analysis. Detailed instructions for using the
EXALT online program features can be found at: http://
seq.mc.vanderbilt.edu/exalt/html/helpIndex.html.
A search tool bar supports seven different search fields
(gene name, gene symbol, tissue type, experiment type,
tumor signature, samples, and multiple genes). These
fields help build a user-defined query against GEO SigDB
or HuCaSigDB. Two drop-down menu lists and one input
text box facilitate selections of a database, a search field,
and an entry of keywords (Figure 1).
Illustration 1: Keyword database search
For instance, to identify human cancer signatures contain-
ing the tumor suppressor gene PTEN, in the first field, a
user chooses the database "Human Cancer Signature DB",
then selects the database search field as "Gene Symbol",
and finally enters the gene symbol, "PTEN" in the text box
(Figure 1).
Once the user has filled out all three fields, the query is
submitted using the "GO" button. This particular query
returns 548 signature records that are displayed initially in
a tabular format. As an option, the user can select to view
a color-coded and annotated plot of PTEN expression lev-
els among human cancer signatures. Figure 2 illustrates
PTEN expression levels in ten human cancer signatures
selected from the full PTEN profile plot. The likelihoods
of differential gene expression levels are represented by
the heights of the bars in units of confidence scores. From
the PTEN profile plot (Figure 2), we observed a common
Multiple search entriesFigure 1
Multiple search entries. From any web page interface of the application, users can access the search tool bar and launch a 
query. The search tool bar supports seven different search fields including gene name, gene symbol, tissue type, experiment 
type, signature, samples, and multiple genes. Two drop-down menu lists are used for the selections of a database and a data-
base field. The input text box accepts key words from the user.Page 3 of 7
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PTEN gene expression among tumor samples with ER+,
grade 3, and tamoxifen treatment.
Illustration 2: Signature homology analysis
Any signature discovered using the EXALT online program
can be used as a query to search for homologous signa-
tures present in the databases. For example, a user may
launch a query by selecting a signature from studies of
estrogen receptor status (ER negative vs ER positive) in
breast cancer [13]. The result of the signature comparisons
is illustrated by a meta-heat map in Figure 3. The homol-
ogous signatures are listed in the rows, and the signature
genes are aligned in alphabetical order in the columns.
The query signature is listed in the first (top) row with
matching subject signatures listed after the query signa-
ture ranked according to signature similarity scores. The
colors in the heat map represent the direction of the dif-
ferential gene expression within a given signature (red for
up, green for down, and black for a missing match), and
color intensities reflect the confidence levels of differential
expression. From this analysis, a cluster of homologous
signatures related to the queried signature can be identi-
fied. The profile suggests that there might be conserved
molecular profiles related to the ER status in breast cancer
across multiple human cancer data sets.
Illustration 3: Gene co-expression analysis
Multiple genes from a known pathway or network can be
investigated to determine if they co-exist in any signatures.
For example, MYC is a well-known oncogene, and PTEN
is a common tumor suppressor gene. Using the EXALT
online program we performed an analysis using the
human cancer signature database to survey the co-expres-
sion profile for these two functionally discordant genes.
The returned signatures were ranked by the sum of Q
scores for the subject signature triplets from highest (top)
to lowest (bottom). Selected results for 10 signature
Meta-gene expression profile across data setsFigure 2
Meta-gene expression profile across data sets. The expression profile in HuCaSigDB from a single gene (PTEN) query is 
plotted. The likelihoods of differential gene expression levels are represented by the heights of the bars in units of confidence 
scores. The differential expression directions in each profile are displayed in two different colors (red for up and green for 
down).
Meta-heat map of ER related signaturesFigure 3
Meta-heat map of ER related signatures. The signature names and PubMed sources are listed in the rows, and signature 
genes are in the columns. The query signature is listed in the first (top) row with matching subject signatures listed after the 
query signature ranked according to signature similarity scores. The colors in the heat map represent the direction of the dif-
ferential gene expression within a given signature (red for up, green for down, and black for a missing match), and color inten-
sities reflect the confidence levels of differential expression.Page 4 of 7
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indicated that some cancer signatures had discordant
expression of MYC and PTEN (Figure 4). All search results
(Figure 2, 3, and 4), including signature data, plotting
source data, and heat map images, can be downloaded
from the EXALT online program.
Discussion
The EXALT online program provides us with a novel way
to search and compare publicly available microarray
results that can help promote widespread and investiga-
tor-driven research on shared data. Our previous report
described signature encoding and formatting, the signa-
ture extraction process, query data uploading, and algo-
rithms for data set comparison [11]. In this study, we
further demonstrated new online features for interrogat-
ing signatures (Figure 2, 3, and 4).
The rationale behind the development of the EXALT
online program is that it is neither feasible nor beneficial
to directly compare raw microarray data. Therefore, we
decided to compare summarized microarray results
through meta-analysis of gene expression signatures. This
strategy enables the EXALT online program to evaluate
data similarity across various microarray platforms. Tradi-
tional heat map presentation often requires fold changes
from the original expression values within a given data
set. However, the fold changes are generally not compara-
ble among different experiments. The EXALT online pro-
gram provides unique output results such as meta-
expression plots and meta-heat maps for data from differ-
ent microarray experiments. These results illustrate differ-
ential gene expression changes using differential
expression directions, similarity scores, and statistical
confidence levels. Thus, we believe that these results allow
rapid perusal of relationships between a query signature
and entries in a database of other microarray experiments.
We are not aware of any other web-based method cur-
rently in use that is capable of searching gene expression
signatures by intrinsic similarities among GEO data sets
and published microarray studies. Current search engines
for gene expression profiles such as GEO and Oncomine
are based on microarray meta-data attributes such as sam-
ple names, experiment descriptions, or a gene ID. The
EXALT online program can perform signature matching
through expression profiles extracted from original micro-
array expression values.
Overlapping gene lists and Venn diagrams have been
commonly used to demonstrate relationships among
related studies. Gene IDs are the only matching factor in
this type analysis, and neither expression direction nor
confidence level is considered. This approach provides an
easy method to compare gene lists within a study and
among published gene lists [14]. However, only limited
number of gene lists can be included in this type of anal-
ysis, and the extent of overlap among gene lists are often
disappointingly low because the lists were generated by
heterogeneous analysis strategies.
Gene Expression Atlas (GeneAtlas at http://
www.ebi.ac.uk/gxa/) from ArrayExpress database[2] pro-
vides an alternative tool to perform gene co-expression
analysis. A user defined input contains a query gene list
with information about the direction of differential
expression and experimental conditions. GeneAtlas dis-
plays summarized experimental results across different
platforms for identifying strong differentially expressed
genes in conditions of interest. A meta-analysis based
Co-expression analysis for multiple query genesFigure 4
Co-expression analysis for multiple query genes. Query genes are labeled in the top of the columns (MYC and PTEN), 
and the subject signatures containing two query genes are in the rows represented by a meta-heat map.Page 5 of 7
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lists is also provided by Oncomine, which includes a com-
prehensive and expertly annotated database of human
cancer signatures [12]. This analytical tool enables the
search and retrieval of cancer-related expression data or a
list of significant genes. However, the comparative meta-
profiling to identify shared gene expression signatures
across several experiments is limited to meta-data
attributes in both GeneAtlas and Oncomine. The meta-
data attributes include experiment descriptions, sample
information, and probe gene IDs. Differential gene
expression data are not comparable across all data sets in
the databases. It remains difficult to identify homologous
data sets sharing similar expression profiles by comparing
microarray results across all studies.
Lamb et al. reported a microrray signature database appli-
cation using a Gene Set Enrichment Analysis (GSEA), and
it is called Connectivity Map (CMAP) [15,16]. The EXALT
online program and CMAP have several important differ-
ences. At the database level, CMAP signature database has
collected only drug-related cancer signatures in 10 cell
lines using the same platform and same experimental
design. The signature databases used by the EXALT online
program include over 28,000 signatures derived from
hundreds of different experimental types and many differ-
ent tissues. CMAP does not require a unified method for
the query signature extraction while in the EXALT online
program all signatures are generated in the same process.
Finally, although both strategies employ a two-group
comparison and signed rank-genes as the basis for signa-
ture encoding format, biological replicates are not
required in CMAP, and no statistical confidence is consid-
ered for each ranked-gene. Signature similarity defined in
the EXALT online program considers all three key ele-
ments (gene ID, direction, and confidence) of gene
expression data. Thus, we believe that the EXALT online
program offers a more accurate, efficient, and cost-effec-
tive way to discover intrinsic similarities and relationships
among gene expression profiles.
Outlook
The EXALT online program is a robust application with a
biological question oriented interface and signature
search capabilities. The main assets are: (1) the EXALT
online program is comprised of two signature databases
that have collections of thousands of signatures, (2) the
signature annotations are integrated with the NCBI GEO
and the PubMed, (3) the multiple mining strategies have
been implemented online to allow directly access and
analysis, (4) the interfaces are friendly to biologists and
clinicians, and knowledge of neither programming lan-
guage nor statistics tool is required, and finally (5) all sig-
natures are pre-computed and potentially more
meaningful to biologists and clinicians.
The next phase of development will include an open web
service API to allow other developers to implement mod-
ules for deeper analysis of gene expression signature appli-
cations. More analysis features and integrations with
other data sources will be implemented to extend the
application. GEO SigDB will be updated regularly with
the latest GEO GDS. More data sets from human cancer
studies will be included in the HuCaSigDB, and our ongo-
ing efforts strive to populate this database with human
cancer signatures derived from at least 1,000 data sets.
Conclusions
The EXALT online program is a software application for
interrogation of thousands of gene expression profiles in
a biologically meaningful contexts. Its architecture sup-
ports multiple search entries to query more than 28,000
pre-computed gene expression signatures from GEO and
human cancer studies. Meta-expression results are graphi-
cally displayed and are straightforward to biologists and
clinicians.
Availability and requirements
•Project name: The EXALT online program
•Project home page: http://seq.mc.vanderbilt.edu/exalt/
•Operating systems: Platform independent
•Programming language: ASP.NET
•Other requirements: Internet connection
•License: Proprietary license. Free for non-commercial
purpose
•Any restriction to use by non-academics: license
needed
Abbreviations
EXALT: (EXpression signature AnaLysis Tool); API: (Appli-
cation Programming Interface); GEO: (Gene Expression
Omnibus); GDS: (Gene expression Data Set); FDR: (false
discovery rate); SigDB: (signature database); HuCaSigDB:
(human cancer SigDB); RDBMS: (relational database
management system); ASP: (Active Server Page).
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